PE20061241A1 - Composicion farmaceutica antifungica que comprende sertaconazol - Google Patents
Composicion farmaceutica antifungica que comprende sertaconazolInfo
- Publication number
- PE20061241A1 PE20061241A1 PE2006000226A PE2006000226A PE20061241A1 PE 20061241 A1 PE20061241 A1 PE 20061241A1 PE 2006000226 A PE2006000226 A PE 2006000226A PE 2006000226 A PE2006000226 A PE 2006000226A PE 20061241 A1 PE20061241 A1 PE 20061241A1
- Authority
- PE
- Peru
- Prior art keywords
- sertaconazole
- composition
- hydrocortisone
- pharmaceutical composition
- composition including
- Prior art date
Links
- 229960005429 sertaconazole Drugs 0.000 title abstract 4
- JLGKQTAYUIMGRK-UHFFFAOYSA-N 1-{2-[(7-chloro-1-benzothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl}imidazole Chemical compound ClC1=CC(Cl)=CC=C1C(OCC=1C2=CC=CC(Cl)=C2SC=1)CN1C=NC=C1 JLGKQTAYUIMGRK-UHFFFAOYSA-N 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 230000000843 anti-fungal effect Effects 0.000 title 1
- 229940121375 antifungal agent Drugs 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 4
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 abstract 2
- HAAITRDZHUANGT-UHFFFAOYSA-N 1-[2-[(7-chloro-1-benzothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole;nitric acid Chemical compound O[N+]([O-])=O.ClC1=CC(Cl)=CC=C1C(OCC=1C2=CC=CC(Cl)=C2SC=1)CN1C=NC=C1 HAAITRDZHUANGT-UHFFFAOYSA-N 0.000 abstract 1
- 206010005913 Body tinea Diseases 0.000 abstract 1
- 241000222122 Candida albicans Species 0.000 abstract 1
- 206010007134 Candida infections Diseases 0.000 abstract 1
- 206010017533 Fungal infection Diseases 0.000 abstract 1
- FOGXJPFPZOHSQS-AYVLZSQQSA-N Hydrocortisone butyrate propionate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)CC)(OC(=O)CCC)[C@@]1(C)C[C@@H]2O FOGXJPFPZOHSQS-AYVLZSQQSA-N 0.000 abstract 1
- DLVOSEUFIRPIRM-KAQKJVHQSA-N Hydrocortisone cypionate Chemical compound O=C([C@@]1(O)CC[C@H]2[C@H]3[C@@H]([C@]4(CCC(=O)C=C4CC3)C)[C@@H](O)C[C@@]21C)COC(=O)CCC1CCCC1 DLVOSEUFIRPIRM-KAQKJVHQSA-N 0.000 abstract 1
- -1 METHYLAMINO Chemical class 0.000 abstract 1
- 208000031888 Mycoses Diseases 0.000 abstract 1
- 208000002474 Tinea Diseases 0.000 abstract 1
- 206010043866 Tinea capitis Diseases 0.000 abstract 1
- 201000003984 candidiasis Diseases 0.000 abstract 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 abstract 1
- 229960001231 choline Drugs 0.000 abstract 1
- ALEXXDVDDISNDU-JZYPGELDSA-N cortisol 21-acetate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)C)(O)[C@@]1(C)C[C@@H]2O ALEXXDVDDISNDU-JZYPGELDSA-N 0.000 abstract 1
- 229960000890 hydrocortisone Drugs 0.000 abstract 1
- 229960001067 hydrocortisone acetate Drugs 0.000 abstract 1
- 229960003331 hydrocortisone cypionate Drugs 0.000 abstract 1
- 229960002846 hydrocortisone probutate Drugs 0.000 abstract 1
- 201000003875 tinea corporis Diseases 0.000 abstract 1
- 201000004647 tinea pedis Diseases 0.000 abstract 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
- B82B3/00—Manufacture or treatment of nanostructures by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
- H01J1/00—Details of electrodes, of magnetic control means, of screens, or of the mounting or spacing thereof, common to two or more basic types of discharge tubes or lamps
- H01J1/02—Main electrodes
- H01J1/30—Cold cathodes, e.g. field-emissive cathode
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Nanotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Manufacturing & Machinery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE: a) SERTACONAZOL EN FORMA DE SERTACONAZOL BASE, MONONITRATO DE SERTACONAZOL, R-SERTACONAZOL BASE O MONONITRATO DE R-SERTACONAZOL QUE SE ENCUENTRA EN UNA CANTIDAD ENTRE 0.1% Y 10% POR PESO DE LA COMPOSICION; b) HIDROCORTISONA EN FORMA DE ACETATO DE HIDROCORTISONA, BUTEPRATO DE HIDROCORTISONA, CIPIONATO DE HIDROCORTISONA, ENTRE OTROS, QUE SE ENCUENTRA EN UNA CANTIDAD ENTRE 0.05% Y 5% POR PESO DE LA COMPOSICION Y c) UN COMPUESTO DE QUINOLONA ANTIBACTERIANO TAL COMO EL ACIDO 1-CICLOPROPIL-8-METIL-7-[5-METIL-6-(METILAMINO)-3-PIRIDINIL]-4-OXO-1,4-DIHIDRO-3-QUINOLIN CARBOXILICO QUE SE ENCUENTRA EN UNA CANTIDAD ENTRE 0.5% Y 10% POR PESO DE LA COMPOSICION. DICHA COMPOSICION ES UTIL EN EL TRATAMIENTO DE INFECCIONES FUNGICAS TAL COMO TINEA PEDIS, TINEA CAPITIS, TINEA CORPORIS, CANDIDIASIS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05101540A EP1698336A1 (en) | 2005-03-01 | 2005-03-01 | Antifungal compositions comprising Sertaconazole and either Hydrocortisone or an antibacterial agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20061241A1 true PE20061241A1 (es) | 2006-11-13 |
Family
ID=34938848
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2006000226A PE20061241A1 (es) | 2005-03-01 | 2006-02-27 | Composicion farmaceutica antifungica que comprende sertaconazol |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20080166398A1 (es) |
| EP (2) | EP1698336A1 (es) |
| JP (1) | JP2008531640A (es) |
| KR (1) | KR20070107806A (es) |
| CN (1) | CN101137362A (es) |
| AR (1) | AR053688A1 (es) |
| AU (1) | AU2006219903A1 (es) |
| BR (1) | BRPI0607561A2 (es) |
| CA (1) | CA2598598A1 (es) |
| MX (1) | MX2007010703A (es) |
| NO (1) | NO20074945L (es) |
| PE (1) | PE20061241A1 (es) |
| RU (1) | RU2007136169A (es) |
| TW (1) | TW200640452A (es) |
| UY (1) | UY29402A1 (es) |
| WO (1) | WO2006092374A1 (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8057433B2 (en) | 2004-07-08 | 2011-11-15 | Drugtech Corporation | Delivery system |
| WO2009114924A1 (en) * | 2008-03-20 | 2009-09-24 | Alda Pharmaceuticals Corp. | Antiseptic compositions for the treatment of infections |
| EP2177208A1 (en) * | 2008-10-17 | 2010-04-21 | Ferrer Internacional, S.A. | Pharmaceutical topical compositions |
| RU2440108C2 (ru) * | 2009-11-12 | 2012-01-20 | Общество с ограниченной ответственностью "ШТАДА ФармДевелопмент" | Фармацевтическая композиция для лечения аллергических и воспалительных заболеваний кожи |
| CN103156862B (zh) * | 2013-03-28 | 2015-04-29 | 孙国栋 | 一种复方伏立康唑滴耳剂及其制备方法 |
| CN107205997A (zh) * | 2015-02-13 | 2017-09-26 | 玛路弘株式会社 | 包含吡啶酮羧酸衍生物的外用制剂 |
| ES2877133T3 (es) * | 2016-07-08 | 2021-11-16 | Acraf | Composición farmacéutica que comprende bencidamina |
| CN113520993B (zh) * | 2021-07-30 | 2022-07-29 | 海南海神同洲制药有限公司 | 一种低粘度硝酸舍他康唑乳膏的制备方法及其制备的产品 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5407663A (en) * | 1991-04-11 | 1995-04-18 | Eisen; Drore | Method of treating inflammatory conditions of the mouth using steroid containing mouthwash which may contain antifungal agents |
| US5578315A (en) * | 1993-12-01 | 1996-11-26 | Rutgers, The State University Of New Jersey | Mucosal adhesive device for long-acting delivery of pharmaceutical combinations in oral cavity |
| ES2273479T3 (es) * | 1998-04-06 | 2007-05-01 | Toyama Chemical Co., Ltd. | Derivados de acidos quinolonacarboxilicos o sales de los mismos. |
| BR0212311A (pt) * | 2001-09-04 | 2004-10-13 | Trommsdorff Arzneimittel | Emplastro para o tratamento de disfunções e distúrbios de unhas |
| US20030091540A1 (en) * | 2001-10-16 | 2003-05-15 | Nawaz Ahmad | Compositions and methods for delivering antibacterial, antifungal and antiviral ointments to the oral, nasal or vaginal cavity |
| ES2203316B1 (es) * | 2002-02-11 | 2005-03-01 | Ferrer Internacional, S.A. | R-(-)-1-(2-(7-cloro-benzo(b)tiofen-3-il-metoxi)-2-(2,4-dicloro-fenil)-etil)1h-imidazol. |
| EP1589972A1 (en) * | 2002-12-31 | 2005-11-02 | Wockhardt Limited | Benzoquinolizine-2-carboxylic acid-containing compositions |
| DE602004021253D1 (de) * | 2003-03-21 | 2009-07-09 | Nexmed Holdings Inc | Antimykotischer nagellack und anwendungsverfahren |
-
2005
- 2005-03-01 EP EP05101540A patent/EP1698336A1/en not_active Withdrawn
-
2006
- 2006-02-22 RU RU2007136169/15A patent/RU2007136169A/ru unknown
- 2006-02-22 WO PCT/EP2006/060190 patent/WO2006092374A1/en not_active Ceased
- 2006-02-22 BR BRPI0607561-4A patent/BRPI0607561A2/pt not_active Application Discontinuation
- 2006-02-22 KR KR1020077022419A patent/KR20070107806A/ko not_active Withdrawn
- 2006-02-22 CA CA002598598A patent/CA2598598A1/en not_active Abandoned
- 2006-02-22 MX MX2007010703A patent/MX2007010703A/es not_active Application Discontinuation
- 2006-02-22 EP EP06724865A patent/EP1858510A1/en not_active Withdrawn
- 2006-02-22 AU AU2006219903A patent/AU2006219903A1/en not_active Abandoned
- 2006-02-22 CN CNA2006800066676A patent/CN101137362A/zh active Pending
- 2006-02-22 US US11/885,554 patent/US20080166398A1/en not_active Abandoned
- 2006-02-22 JP JP2007557469A patent/JP2008531640A/ja active Pending
- 2006-02-24 UY UY29402A patent/UY29402A1/es unknown
- 2006-02-27 PE PE2006000226A patent/PE20061241A1/es not_active Application Discontinuation
- 2006-02-27 TW TW095106521A patent/TW200640452A/zh unknown
- 2006-03-01 AR ARP060100758A patent/AR053688A1/es unknown
-
2007
- 2007-10-01 NO NO20074945A patent/NO20074945L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2598598A1 (en) | 2006-09-08 |
| US20080166398A1 (en) | 2008-07-10 |
| JP2008531640A (ja) | 2008-08-14 |
| WO2006092374A1 (en) | 2006-09-08 |
| CN101137362A (zh) | 2008-03-05 |
| EP1698336A1 (en) | 2006-09-06 |
| UY29402A1 (es) | 2006-06-30 |
| MX2007010703A (es) | 2007-10-12 |
| AR053688A1 (es) | 2007-05-16 |
| BRPI0607561A2 (pt) | 2009-09-15 |
| EP1858510A1 (en) | 2007-11-28 |
| AU2006219903A1 (en) | 2006-09-08 |
| KR20070107806A (ko) | 2007-11-07 |
| NO20074945L (no) | 2007-11-21 |
| TW200640452A (en) | 2006-12-01 |
| RU2007136169A (ru) | 2009-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO6612278A2 (es) | Composición acuosa antitranspirante/desodorante | |
| CO6280584A2 (es) | Derivados heterociclicos fungicidas de (tetrazolil-benzilideneamido)-oximetil | |
| CR9832A (es) | Compuestos de pirimidina amida como inhibidores de pgds | |
| GT200500159A (es) | (orto-fenil)-anilidas de àcido 1-metil-3-trifluorometil-pirazol-4-carboxìlico y su uso como fungicida | |
| PE20120342A1 (es) | Formulacion de anticuerpo | |
| MX2013005407A (es) | 5-halopirazolcarboxamidas. | |
| AR109135A2 (es) | Forma sólida de una sal hidratada de tartrato de un compuesto de pirrolidina inhibidor de dpp-iv | |
| UY32714A (es) | Mezclas fungicidas | |
| ECSP088313A (es) | Derivados plaguicidas de fenilamidina sustituida con pirimidiniloxi | |
| GT200600356A (es) | Mezclas fungicidas que contienen anilidas sustituidas de acido 1-metilpirazol-4-ilcarboxilico. | |
| BRPI0516019A (pt) | composições para o uso contra um ou mais agentes patogênicos | |
| PE20230684A1 (es) | Analogos de carba-nucleosidos sustituidos con 2'-fluoro como inhibidores de la arn polimerasa | |
| CO6361849A2 (es) | Derivados de n-cicloalquil-nbifenilmetil-carboxamida fungicidas | |
| PE20141552A1 (es) | Composiciones farmaceuticas | |
| ECSP099790A (es) | Suspensiones de sustancias activas en glicerol | |
| SV2009002861A (es) | Compuestos de pirimidina amida como inhibidores de pgds | |
| PE20061241A1 (es) | Composicion farmaceutica antifungica que comprende sertaconazol | |
| CO6710899A2 (es) | Composiciones para el control de patógenos en plantas y método para su uso | |
| MX2010007677A (es) | Derivados de hidroximoil-tetrazol como fungicidas. | |
| AR056751A1 (es) | Composiciones pesticidamente activas que tienen actividad mejorada | |
| UY35352A (es) | ?composición de glifosato para mezclas de tanque con dicamba con volatilidad mejorada?. | |
| UY30778A1 (es) | Compuestos de 5,6-dihidro-1h-piridin-2-ona | |
| AR063825A1 (es) | Metodo de tratamiento para telas y composicion para impartir hidrofobicidad diferencial | |
| AR061709A1 (es) | Farmaco de silicato de aluminio y calcio | |
| HN2008000582A (es) | Composiciones de suplementos de hierro de tolerancia mejorada |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |